Marcel R.M. van den Brink has been named Head of the Division of Hematologic Oncology in the Department of Medicine.
Dr. van den Brink is a physician-scientist who is an expert in allogeneic (donor-provided) blood stem cell transplantation for adult cancer patients. He also heads a laboratory in Sloan-Kettering Institute's Immunology Program, which focuses on the immunology of bone marrow transplantation and the role of T cells in graft-versus-host disease (a potentially fatal complication of transplantation in which the donor's immune cells attack the recipient's tissues). Dr. van den Brink earned his MD and PhD degrees from Leiden University, in the Netherlands. He was a resident in internal medicine at Duke University Medical Center and then a hematology/oncology fellow at Beth Israel Deaconess Medical Center, in Boston. He joined Memorial Sloan-Kettering in 1999 and in 2005 was named Chief of the Adult Bone Marrow Transplant Service. He is the incumbent of the Alan N. Houghton Chair.
